Edgewell Personal Care (EPC) FY2012 results: revenue $4.6 billion, down 1.7% on the year
Edgewell Personal Care Co. (EPC) reported revenue of $4.6 billion for fiscal 2012, the year ended 30 September 2012, down 1.7% on the year before. Net income was $409 million, up 56.5%, and diluted earnings per share $6.22. The figures are the company's own, from the 10-K it filed with the SEC on 20 November 2012.
Revenue
$4.6 billion
-1.7% on the year
FY2008FY2012
Operating margin
n/a
FY2008FY2012
Net income
$409 million
+56.5% on the year
FY2008FY2012
Diluted EPS
$6.22
+67.2% on the year
FY2008FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
4,567
4,646
4,248
-1.7%
Cost of revenue
2,429
2,500
2,229
-2.8%
Gross profit
2,138
2,146
2,019
-0.4%
Gross margin
46.8%
46.2%
47.5%
Research and development
112
108
97.1
+3.9%
Interest expense
127
121
125
+4.9%
Pre-tax income
565
406
543
+39.3%
Income tax
156
145
140
+8.1%
Effective tax rate
27.7%
35.7%
25.8%
Net income
409
261
403
+56.5%
Net margin
9.0%
5.6%
9.5%
Diluted EPS
$6.22
$3.72
$5.72
+67.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
632
412
652
+53.1%
Capital expenditure
111
98.0
109
+13.3%
Free cash flow
521
314
544
+65.5%
Free cash flow margin
11.4%
6.8%
12.8%
Cash from investing
-94.9
-364
-113
Cash from financing
-283
-202
-234
Depreciation and amortisation
162
181
139
-10.5%
Share-based compensation
44.9
37.3
28.2
+20.4%
Buybacks
418
276
0.0
+51.4%
Dividends paid
24.9
0.0
0.0
Diluted shares, weighted
66m
70m
70m
-6.5%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
2,070
2,101
2,100
-1.5%
Debt
2,532
2,368
2,313
+6.9%
Other liabilities
2,129
2,062
1,975
+3.3%
Total liabilities and equity
6,731
6,532
6,388
+3.1%
Fixed assets
848
885
841
-4.2%
Goodwill
1,470
1,475
1,316
-0.4%
Intangible assets
1,854
1,878
1,774
-1.3%
Cash and equivalents
718
471
630
+52.5%
Receivables
677
710
825
-4.7%
Inventory
672
653
666
+2.9%
Other assets
492
458
336
+7.4%
Total assets
6,731
6,532
6,388
+3.1%
10-K for the year ended 30 September 2012, filed 20 November 2012: the filing.